foxo4 dri protocol Frontiers FOXO4-DRI: Human Trial Status, Cancer

Right After Your Session Most people feel hydrated and refreshed within an hour or two

As a cytoprotective agent (reviewed [4,5,6]), it may be a suitable form of treatment for pulmonary arterial hypertension, a disease characterized by progressive pulmonary vascular remodeling, resulting in right-side heart failure and premature death in rats given monocrotaline (reviewed [15,16])

MOTS-C optimizes mitochondrial function and cellular energy production, enhancing physical performance, reducing fatigue, and supporting metabolic health and body composition

The course supports safer consultation conversations and progression planning, but it does not replace supervised hands-on treatment experience